TipRanks
Advertisement
Advertisement
Lantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection
PremiumThe FlyLantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection
24d ago
Lantheus announces first patient dosed in Phase 2/3 trial of LNTH-2401
Premium
The Fly
Lantheus announces first patient dosed in Phase 2/3 trial of LNTH-2401
26d ago
Lantheus announces U.S. FDA granted final approval for Bravnesta
Premium
The Fly
Lantheus announces U.S. FDA granted final approval for Bravnesta
1M ago
Lantheus reports Q2 adjusted EPS $1.55, consensus $1.30
PremiumThe FlyLantheus reports Q2 adjusted EPS $1.55, consensus $1.30
3M ago
Lantheus downgraded to Market Perform from Outperform at CJS Securities
Premium
The Fly
Lantheus downgraded to Market Perform from Outperform at CJS Securities
3M ago
Curium to Acquire Lantheus, Taking Company Private
Premium
Company Announcements
Curium to Acquire Lantheus, Taking Company Private
3M ago
Lantheus downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyLantheus downgraded to Market Perform from Outperform at Leerink
3M ago
Lantheus downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Lantheus downgraded to Market Perform from Outperform at William Blair
3M ago
Curium to Acquire Lantheus in $8 Billion Merger
Premium
Company Announcements
Curium to Acquire Lantheus in $8 Billion Merger
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―